Aromatase inhibitors, bone microstructure, and estimated bone strength in postmenopausal women with breast cancer: a 5-year prospective study

World Health Organization. GLOBOCAN Breast Fact Sheet. Available at: https://gco.iarc.who.int/media/globocan/factsheets/cancers/20-breast-fact-sheet.pdf.

Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ (2019) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol 37:423–438

Article  CAS  PubMed  Google Scholar 

Terada M, Ito A, Kikawa Y, Koizumi K, Naito Y et al (2023) The japanese breast cancer society clinical practice guidelines for systemic treatment of breast cancer, 2022 edition. Breast Cancer 30:872–884

Article  PubMed  Google Scholar 

Loibl S, André F, Bachelot T, Barrios CH, Bergh J et al (2024) Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 35:159–182

Article  CAS  PubMed  Google Scholar 

Kuba S, Watanabe K, Chiba K, Matsumoto M, Yamanouchi K, Fukushima A, Meng X, Morita M, Otsubo R, Yano H, Kanetaka K, Osaki M, Nagayasu T, Eguchi S (2021) Adjuvant endocrine therapy effects on bone mineral density and microstructure in women with breast cancer. J Bone Miner Metab 39:1031–1040

Article  CAS  PubMed  Google Scholar 

Chiba K, Okazaki N, Kurogi A, Isobe Y, Yonekura A, Tomita M, Osaki M (2018) Precision of second-generation high-resolution peripheral quantitative computed tomography: intra- and intertester reproducibilities and factors involved in the reproducibility of cortical porosity. J Clin Densitom 21:295–302

Article  PubMed  Google Scholar 

Pialat JB, Burghardt AJ, Sode M, Link TM, Majumdar S (2012) Visual grading of motion induced image degradation in high resolution peripheral computed tomography: impact of image quality on measures of bone density and micro-architecture. Bone 50:111–118

Article  CAS  PubMed  Google Scholar 

Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458

Article  CAS  PubMed  Google Scholar 

Cheung AM, Tile L, Cardew S, Pruthi S, Robbins J, Tomlinson G, Kapral MK, Khosla S, Majumdar S, Erlandson M, Scher J, Hu H, Demaras A, Lickley L, Bordeleau L, Elser C, Ingle J, Richardson H, Goss PE (2012) Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol 3:275–284

Article  Google Scholar 

Ramchand SK, Seeman E, Wang XF, Ghasem-Zadeh A, Francis PA, Ponnusamy EJ, Bardin MS, Bui M, Zebaze R, Zajac JD, Grossmann M (2017) Premenopausal women with early breast cancer treated with estradiol suppression have severely deteriorated bone microstructure. Bone 103:131–135

Article  CAS  PubMed  Google Scholar 

Hong N, Burm SW, Treece G, Kim JY, Kim MH, Lee S, Shin S, Rhee Y (2021) Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: A three-dimensional cortical bone mapping study. J Bone Oncol 32:100409

Article  PubMed  PubMed Central  Google Scholar 

Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R et al (2015) Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 386:433–443

Article  CAS  PubMed  Google Scholar 

Nenonen A, Cheng S, Ivaska KK, Alatalo SL, Lehtimäki T, Schmidt-Gayk H, Uusi-Rasi K, Heinonen A, Kannus P, Sievänen H, Vuori I, Väänänen HK, Halleen JM (2005) Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J Bone Miner Res 20:1804–1812

Article  CAS  PubMed  Google Scholar 

Ouchi Y, Nakatsukasa K, Sakaguchi K, Morita M, Koyama H, Matsuda T, Kato M, Konishi E, Ono H, Tetsuya Taguchi T (2021) The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results. J Bone Miner Metab 39:224–229

Article  CAS  PubMed  Google Scholar 

Kuba S, Niimi R, Chiba K, Matsumoto M, Hara Y, Fukushima A, Tanaka A, Akashi M, Morita M, Inamasu E, Otsubo R, Kanetaka K, Osaki M, Matsumoto K, Eguchi S (2024) Chemotherapy effects on bone mineral density and microstructure in women with breast cancer. J Bone Miner Metab. https://doi.org/10.1007/s00774-024-01526-2

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif